Jacobs Levy Equity Management, Inc Viatris Inc Transaction History

Jacobs Levy Equity Management, Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$8.72 - $11.56 $5.8 Million - $7.69 Million	-665,571 Reduced 11.26%	5,243,392 $58.4 Million
Q3 2022 Nov 15, 2022	BUY	$8.48 - $11.13 $12.2 Million - $16.1 Million	1,444,317 Added 32.35%	5,908,963 $50.3 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $19.6 Million - $24.2 Million	1,973,856 Added 79.25%	4,464,646 $46.7 Million
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $10.1 Million - $15.8 Million	1,027,154 Added 70.18%	2,490,790 $27.1 Million
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $11.7 Million - $14.2 Million	968,841 Added 195.81%	1,463,636 $19.8 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $21 Million - $24 Million	-1,584,421 Reduced 76.2%	494,795 $6.7 Million
Q2 2021 Aug 16, 2021	BUY	$12.97 - $16.15 $400,824 - $499,099	30,904 Added 1.51%	2,079,216 $29.7 Million
Q1 2021 May 17, 2021	BUY	$13.59 - $18.54 $310,259 - $423,268	22,830 Added 1.13%	2,048,312 $28.6 Million
Q4 2020 Feb 16, 2021	BUY	$14.3 - $18.74 $29 Million - $38 Million	2,025,482 New	2,025,482 $38 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.